As we and others reported last month, a very early diagnosis of bipolar disorder was one of the probable factors that led to a young child’s death. I’m sorry, but unless it’s an extreme exception, adult diagnoses such as bipolar disorder are not recognized in children at 2 or even 3 years old. Children at such young ages are under active, constantly-changing development. There are no widely-accepted, legitimate diagnostic criteria for children generally under 12 for bipolar disorder.
So we were happy to see Furious Seasons write up John McManamy’s take on this issue today.
But one of the challenges of bloggers and folks trying to make heads or tails of this issue is not spending the time (or perhaps have the access to the resources) to critically look at the research. A full-scale literature review takes a lot of effort, even for a trained professional. So I’ll take an outsider’s crack at this topic in more detail here, because I do have access to the resources and some key journal articles that shed light on bipolar disorder in children.
I look for two things in the literature when I want to get up to speed on an area of interest to me. I look for literature reviews and meta-analyses. These overview articles, when appearing in a peer-reviewed journal, offer non-expects like myself a critical 10,000 foot view of the sub-field.
The first such lit review I found was Geller and Luby (1997). Their reference list alone included more than 8 dozen citations to studies mentioned in their article. This article clearly shows empirical support for a syndrome similar to adult bipolar disorder in children, but in 1997, there was still not agreed-upon diagnostic criteria for this phemenon. So while many researchers were writing about children who showed symptoms similar to that of adult bipolar disorder, nobody had done any of the foundational work to say, “This is indeed childhood bipolar disorder and these are its symptoms.” The authors also noted that, as of 1997, there was only one completed, double-blind, placebo-controlled study of any medication for child or adolescent mania. That’s just 10 years ago.
Jumping ahead eight years later, though, for the most recent meta-analysis on this topic, and we still see no clear, agreed-upon diagnostic criteria in Kowatch et al.’s 2005 study. While the study suggested a set of criteria based upon its data analysis, these criteria (like most research) are likely not widely known or disseminated amongst clinicians.
I think the most telling result of the past decade’s worth of further research into this issue comes from Pavuluri et al’s 2005 conclusions:
Considerable advances have been made in our knowledge of pediatric bipolar disorder (BD); however, differing viewpoints on the clinical presentation of BD in children are the rule [emphasis added]. Phenomenological and longitudinal studies and biological validation using genetic, neurochemical, neurophysiological, and neuroimaging methods may strengthen our understanding of the phenocopy. Randomized, controlled treatment studies for the acute and maintenance treatment of BD disorder are warranted.
They also noted,
Combination pharmacotherapies appear promising, and the field awaits further short- and long-term randomized, placebo-controlled trials.
Not exactly a ringing endorsement for the use of any pharmcological treatment for the treatment of bipolar disorder in children, now is it?
More recent studies, such as Singh et al.’s 2006 literature review, also illustrate the complex interaction between ADHD and bipolar diagnoses — that making a bipolar disorder diagnosis without taking into account ADHD as a differential can lead to misdiagnosis.
The key here is that while clinicians and researchers agree that some form of bipolar disorder seems to exist within children and adolescents, virtually nothing is agreed upon when it comes to the form, nature and treatment of that disorder. Clinicians are out there doing what they normally do — doing the best they can with the presenting problems of clients (or their parents), while researchers are coming at the issue from a dozen different angles.
Seeing it from this light, we can understand the confusion and lack of practice guidelines in this area. But as a clinician, when confronted with such a challenging area as this, I would think most would err on the side of being fairly conservative in their treatment. Especially of a child. And especially of a very, very young child with powerful psychopharmacological treatments that have only small amounts of empirical support at present (with absolutely no long-term, logitudinal studies done on children to ensure these medications don’t have serious, long-term detrimental developmental side effects).
Cheng-Shannon et al. (2004) said it best when it comes to prescribing powerful antipsychotic medications in children and adolescents —
Although these medications appear to be well tolerated in short-term studies, long-term follow-up investigations and ongoing clinical monitoring are necessary to confirm their safety in this age group.
References
Cheng-Shannon, J. et al. Second-Generation Antipsychotic Medications in Children and Adolescents. Journal of Child and Adolescent Psychopharmacology, Vol 14(3), Fal 2004. pp. 372-394.
Geller, B. and Luby, J. “Child and adolescent bipolar disorder: a review of the past 10 years.” Journal of the American Academy of Child and Adolescent Psychiatry 36.n9 (Sept 1997): 1168(9).
Kowatch, R.A. et al. Review and meta-analysis of the phenomenology and clinical characteristics of mania in children and adolescents. Bipolar Disorders, Vol 7(6), Dec 2005. pp. 483-496.
Pavuluri, M.N. et al. Pediatric Bipolar Disorder: A Review of the Past 10 Years. Journal of the American Academy of Child & Adolescent Psychiatry, Vol 44(9), Sep 2005. pp. 846-871.
Singh, M. et al. Co-occurrence of bipolar and attention-deficit hyperactivity disorders in children. Bipolar Disorders, Vol 8(6), Dec 2006. pp. 710-720.
4 comments
I too am following this issue of bipolar illness in children. What I find interesting in what I have read so far — and I have not gone back as you did to look at much of the research done so far — is an absence of curiosity about why the upswing in prevalence of this problem and very little, except from critics, about the tendency to label anything other than perfect behavior as pathological. Have we really become Lake Wobegone, where all the children are above average — and those who are not are on meds? Think about the memorable naughty children from children’s lit — would they now be slapped with a psychiatric diagnosis and medicated out of their naughtiness?
And, is there any data at all on whether children exhibiting the behaviors which result in the diagnosis of bipolar illness actually go on to fit the diagnosis as adults? I realize that wishing for a longitudinal study is its own madness, but wouldn’t that seem to be an important question to answer?
Barb Geller is a key-player in the C.A.B.F bp kids bipolar child website which heavily promoted medicating children with Early Onset Childhood Bipolar Disorder.
Keep digging.You will soon find the most outspoken, and pro-medications, pro-belief in the Childhood Bipolar Paradigm are all connected, and Pharma-funded.
i am a bipolar II. full university scholarship based on Selling poetry in HS. have founded multiple lite-industries, been worth 17-21 $mil, and crashed to welfare and tents. before exposure to ‘the mental-health’ system, lithium, librium, and absolutely demolishing risperdal(for depression)i always came back. the FDA is a killer.
the idea of any ‘Big Pharma’ exploitation of anyone, as i or a child? criminal. LOOK at the 2006 Emory U ‘real-life’ study of neuroleptics and bipolars—they found a 60% damage-rate vs. far smaller drug co. sponsored studies. these drugs are often termed a chemical lobotomy, at the least they swiftly may covert a bipolar to a schizo-affective, or full schizophrenic. it’s all over ‘survior-forums’, big topic of real victims.
you have no idea, lest you be there. plenty of clinical data, if you look. anyone participating in drugging children is no better than hitler. considering the scope of such disaster, perhaps worse—and simple to understand—‘the love of $$$….’ it is not Ethical—but enormous crime. the former KGB used neuroleptics on some apprehended ‘double-agents’, reducing them to horrors, and displayed to their new agents as a warning—this you would permit ‘Big Pharma’ to administer to your child? Get Smart. Please—